⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for stage ii small lymphocytic lymphoma

Every month we try and update this database with for stage ii small lymphocytic lymphoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Vorinostat, Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaNCT00918723
Chronic Lymphoc...
Stage I Chronic...
Stage I Small L...
Stage II Chroni...
Stage II Small ...
Stage III Chron...
Stage III Small...
Stage IV Chroni...
Stage IV Small ...
Fludarabine Pho...
Cyclophosphamid...
Rituximab
Vorinostat
18 Years - Fred Hutchinson Cancer Center
Vorinostat, Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaNCT00918723
Chronic Lymphoc...
Stage I Chronic...
Stage I Small L...
Stage II Chroni...
Stage II Small ...
Stage III Chron...
Stage III Small...
Stage IV Chroni...
Stage IV Small ...
Fludarabine Pho...
Cyclophosphamid...
Rituximab
Vorinostat
18 Years - Fred Hutchinson Cancer Center
Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic LeukemiaNCT00541034
Leukemia
Lymphoma
rituximab
cyclophosphamid...
pentostatin
18 Years - 120 YearsMemorial Sloan Kettering Cancer Center
Ofatumumab, Pentostatin, and Cyclophosphamide in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaNCT01024010
Chronic Lymphoc...
Stage 0 Chronic...
Stage I Chronic...
Stage I Small L...
Stage II Chroni...
Stage II Small ...
Stage III Chron...
Stage III Small...
Stage IV Chroni...
Stage IV Small ...
Cyclophosphamid...
Laboratory Biom...
Ofatumumab
Pentostatin
18 Years - Mayo Clinic
Cyclophosphamide, Alvocidib, and Rituximab in Treating Patients With High Risk B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaNCT01076556
Chronic Lymphoc...
Prolymphocytic ...
Recurrent Small...
Refractory Chro...
Stage I Chronic...
Stage I Small L...
Stage II Chroni...
Stage II Small ...
Stage III Chron...
Stage III Small...
Stage IV Chroni...
Stage IV Small ...
Alvocidib Hydro...
Cyclophosphamid...
Diagnostic Labo...
Pharmacological...
Rituximab
18 Years - National Cancer Institute (NCI)
Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell LymphomasNCT02213913
Adult Grade III...
B-cell Chronic ...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Cutaneous B-cel...
Extranodal Marg...
Intraocular Lym...
Nodal Marginal ...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Progressive Hai...
Small Intestine...
Splenic Margina...
Stage 0 Chronic...
Stage I Adult D...
Stage I Adult D...
Stage I Adult D...
Stage I Adult H...
Stage I Adult I...
Stage I Chronic...
Stage I Grade 1...
Stage I Grade 2...
Stage I Grade 3...
Stage I Mantle ...
Stage I Margina...
Stage I Small L...
Stage II Adult ...
Stage II Chroni...
Stage II Small ...
Stage III Adult...
Stage III Adult...
Stage III Adult...
Stage III Adult...
Stage III Adult...
Stage III Chron...
Stage III Grade...
Stage III Grade...
Stage III Grade...
Stage III Mantl...
Stage III Margi...
Stage III Small...
Stage IV Adult ...
Stage IV Adult ...
Stage IV Adult ...
Stage IV Adult ...
Stage IV Adult ...
Stage IV Chroni...
Stage IV Grade ...
Stage IV Grade ...
Stage IV Grade ...
Stage IV Mantle...
Stage IV Margin...
Stage IV Small ...
Testicular Lymp...
Untreated Hairy...
Waldenström Mac...
lenalidomide
etoposide
prednisone
vincristine sul...
doxorubicin hyd...
cyclophosphamid...
rituximab
quality-of-life...
laboratory biom...
18 Years - University of Chicago
Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's LymphomaNCT00004112
Lymphoma
rituximab
CHOP regimen
cyclophosphamid...
doxorubicin hyd...
prednisone
vincristine sul...
19 Years - 120 YearsUniversity of Nebraska
SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ TransplantNCT00002657
Lymphoma
Multiple Myelom...
bleomycin sulfa...
recombinant int...
cyclophosphamid...
cytarabine
doxorubicin hyd...
etoposide
methotrexate
prednisone
vincristine sul...
conventional su...
radiation thera...
15 Years - SWOG Cancer Research Network
Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin LymphomaNCT00288067
Adult Nodular L...
B-cell Chronic ...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Contiguous Stag...
Stage II Margin...
Stage II Small ...
Extranodal Marg...
Nodal Marginal ...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Noncontiguous S...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Grade...
Recurrent Grade...
Recurrent Mantl...
Recurrent Margi...
Recurrent Small...
Refractory Chro...
Splenic Margina...
Stage I Adult B...
Stage I Adult D...
Stage I Adult H...
Stage I Adult L...
Stage I Chronic...
Stage I Grade 1...
Stage I Grade 2...
Stage I Small L...
Stage II Adult ...
Stage II Chroni...
Stage III Adult...
Stage III Adult...
Stage III Adult...
Stage III Adult...
Stage III Chron...
Stage III Grade...
Stage III Grade...
Stage III Mantl...
Stage III Margi...
Stage III Small...
Stage IV Adult ...
Stage IV Adult ...
Stage IV Adult ...
Stage IV Adult ...
Stage IV Chroni...
Stage IV Grade ...
Stage IV Grade ...
Stage IV Mantle...
Stage IV Margin...
Stage IV Small ...
Waldenström Mac...
fenretinide
rituximab
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: